Harry Yoon, MD, Oncology, Rochester, MN, Mayo Clinic Hospital - Rochester

HarryYoonMD

Oncology Rochester, MN

Gastrointestinal Cancer, Hematologic Oncology

Mayo Clinic

Dr. Yoon is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yoon's full profile

Already have an account?

Summary

  • I am a board-certified medical oncologist with a clinical specialization in GI cancers and cancers of unknown primary (CUP) My research focuses on clinical trials of novel agents and translational investigations in gastroesophageal and colorectal cancer and in CUP.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFELLOWSHIP
  • Yale-New Haven Hospital
    Yale-New Haven HospitalRESIDENCY
  • Yale University School of Medicine
    Yale University School of MedicineMEDICAL_SCHOOL
  • Johns Hopkins University Schools of Medicine and Public HealthOTHER_TRAINING

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2008 - 2021
  • MD State Medical License
    MD State Medical License 2004 - 2009
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • From Standardization to Personalized Care: How to Use Molecular Diagnostics to Guide Treatment 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • Tislelizumab plus chemotherapy as first-line treatment for unresectable, locally advanced recurrent/metastatic esophageal squamous cell carcinoma. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • CD3+ and CD8+ tumor-infiltrating lymphocyte (TIL) densities to prognostically stratify DNA mismatch repair-deficient (dMMR) colon cancer patients (pts): NCCTG N0147 (A... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Other

Authored Content

  • How Immunotherapy Is Transforming GI Cancer TreatmentJanuary 2019

Press Mentions

  • For Esophageal Cancer, Immunotherapy Likely to Play Larger Role
    For Esophageal Cancer, Immunotherapy Likely to Play Larger RoleNovember 05, 2020 14:04
  • Expert Discusses Continued Growth of Immunotherapy in Gastric/GEJ Cancer
    Expert Discusses Continued Growth of Immunotherapy in Gastric/GEJ CancerOctober 07, 2017 10:39
  • OncLive® Presents State of the Science Summit™ on Gastrointestinal Malignancies – Update from European Society of Medical Oncology
    OncLive® Presents State of the Science Summit™ on Gastrointestinal Malignancies – Update from European Society of Medical OncologySeptember 08, 2017 10:52
  • Join now to see all

Professional Memberships

Hospital Affiliations